Latanotim (Timolol Maleate, Latanoprost)

• Latanotim is a combination ophthalmic therapy used to manage conditions that involve elevated intra‑ocular pressure.
• Open‑angle glaucoma: reduces intra‑ocular pressure to help preserve visual field.
• Ocular hypertension: lowers pressure to prevent progression to glaucoma.
• Secondary glaucoma (where applicable): assists in pressure control when other agents are insufficient.

• Timolol maleate blocks beta‑adrenergic receptors in the ciliary body, decreasing aqueous humor production, while latanoprost, a prostaglandin F2α analog, enhances uveoscleral outflow by remodeling extracellular matrix. The dual action synergistically reduces intra‑ocular pressure, addressing both production and drainage pathways.

Latanotim may cause ocular and systemic reactions.

Common Side Effects

• Blurred vision or transient visual disturbance.
• Eye irritation, burning or stinging on instillation.
• Conjunctival hyperemia (red eye).
• Increased eyelash growth or darkening of the iris.
• Dry eye sensation.

Serious or Rare Side Effects

• Severe allergic reaction with swelling or rash.
• Systemic beta‑blocker effects such as bradycardia, hypotension, or bronchospasm.
• Ocular inflammation or worsening of pre‑existing eye disease.
• Periorbital fat atrophy leading to facial changes.
• Persistent changes in iris color that may be irreversible.

• Before using Latanotim, consider the following safety measures.
• Cardiovascular assessment: evaluate for bradycardia, heart block, or heart failure.
• Respiratory caution: avoid in patients with asthma or severe COPD due to beta‑blocker activity.
• Systemic beta‑blocker use: monitor for additive effects if the patient is already on oral beta‑blockers.
• Allergy screening: do not use if there is known hypersensitivity to timolol, latanoprost, or any excipients.
• Pregnancy and lactation: use only if the potential benefit justifies the potential risk.
• Store at room temperature: keep in the original container, protect from light and moisture.

Latanotim can interact with other medications; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Systemic non‑selective beta‑blockers: may cause excessive bradycardia or hypotension.
• Epinephrine eye drops: can antagonize the IOP‑lowering effect.
• Other prostaglandin analogs: additive ocular side effects.

Moderate Interactions (Monitor Closely)

• Antihypertensive agents: monitor blood pressure for additive lowering.
• Asthma medications (e.g., beta‑agonists): watch for reduced bronchodilator response.
• Other intra‑ocular pressure‑lowering drugs: assess for over‑reduction of pressure.